OUR TEAM
Mauro Mileni, PhD
Founder & CEO
Mauro Mileni, PhD
Founder & CEO
Michael Hanson, PhD
CSO
Jim Schmidt
CFO
Jim Schmidt
CFO
Christopher B. Roth, PhD
Vice President, Research
Christopher B. Roth, PhD
Vice President, Research
Alexander Alexandrov, PhD
Associate Director
Alexander Alexandrov, PhD
Associate Director
Karen Chiang, PhD
Research Scientist
Karen Chiang, PhD
Research Scientist
Roberto Jappelli, PhD
Principal Scientist
Roberto Jappelli, PhD
Principal Scientist
Sunghoon Kim, PhD
Research Scientist
Sunghoon Kim, PhD
Research Scientist
Le Li, PhD
Research Scientist
Le Li, PhD
Research Scientist
Kin Moy, BSc
Lab Manager/Research Associate
Kin Moy, BSc
Lab Manager/Research Associate
DIRECTORS OF THE BOARD
Daniel Bradbury
Director of the Board
Daniel Bradbury
Director of the Board
Michael Goguen
Director of the Board
Michael Goguen
Director of the Board
Mauro Mileni
Founder & CEO
Mauro Mileni
Founder & CEO
Rachel Tsunemoto Hislop
Observer
Rachel Tsunemoto Hislop
Observer
SCIENTIFIC ADVISORS
Tom Boone
Antibody Discovery and Development Advisor
Tom Boone
Antibody Discovery and Development Advisor
Prof. Tracy Handel, PhD
Pharmacology Advisor
Prof. Tracy Handel, PhD
Pharmacology Advisor
Fred Ramsdell, PhD
Oncology Advisor
Fred Ramsdell, PhD
Oncology Advisor
Laura Solforosi, PhD
Antibodies & Vaccines Advisor
Laura Solforosi, PhD
Antibodies & Vaccines Advisor
EXECUTIVE ADVISORS
Don Rindell
Managing Director of Camino International
Don Rindell
Managing Director of Camino International
Charlie Rodi, PhD
Founder and CEO of RhoDx, Inc.
Charlie Rodi, PhD
Founder and CEO of RhoDx, Inc.
R. Scott Struthers, PhD
CEO of Crinetics Pharmaceuticals
R. Scott Struthers, PhD
CEO of Crinetics Pharmaceuticals